- Home
- SOLV vs NBIX Comparison
SOLV vs NBIX Comparison
Compare SOLV & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOLV
- NBIX
- Stock Information
- Founded
- SOLV 2023
- NBIX 1992
- Country
- SOLV United States
- NBIX United States
- Employees
- SOLV N/A
- NBIX N/A
- Industry
- SOLV
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOLV
- NBIX Health Care
- Exchange
- SOLV NYSE
- NBIX Nasdaq
- Market Cap
- SOLV 12.7B
- NBIX 12.4B
- IPO Year
- SOLV N/A
- NBIX 1996
- Fundamental
- Price
- SOLV $74.05
- NBIX $135.13
- Analyst Decision
- SOLV Hold
- NBIX Strong Buy
- Analyst Count
- SOLV 11
- NBIX 21
- Target Price
- SOLV $80.29
- NBIX $165.14
- AVG Volume (30 Days)
- SOLV 779.9K
- NBIX 843.2K
- Earning Date
- SOLV 08-07-2025
- NBIX 07-30-2025
- Dividend Yield
- SOLV N/A
- NBIX N/A
- EPS Growth
- SOLV N/A
- NBIX N/A
- EPS
- SOLV 2.18
- NBIX 2.96
- Revenue
- SOLV $8,308,000,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- SOLV $4.11
- NBIX $16.29
- Revenue Next Year
- SOLV $0.14
- NBIX $15.08
- P/E Ratio
- SOLV $34.05
- NBIX $45.69
- Revenue Growth
- SOLV 1.29
- NBIX 21.73
- 52 Week Low
- SOLV $47.16
- NBIX $84.23
- 52 Week High
- SOLV $85.92
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- SOLV N/A
- NBIX 70.48
- Support Level
- SOLV N/A
- NBIX $127.03
- Resistance Level
- SOLV N/A
- NBIX $135.94
- Average True Range (ATR)
- SOLV 0.00
- NBIX 2.95
- MACD
- SOLV 0.00
- NBIX 0.49
- Stochastic Oscillator
- SOLV 0.00
- NBIX 93.72
About SOLV SOLVENTUM CORP
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.